SIRT3 and breast carcinoma: Either SIRT3 or SIRT5 gene-deletion mice are prone to age-associated diseases [79,80]; however, conflicting results are also shown in breast cancer, indicating that silencing SIRT3 sensitizes the cancer cells for cytotoxic treatments [81].